Thermo Fisher Scientific (NYSE:[[ticker:TMO]]), a Waltham, MA-based provider of scientific research products and services, says that it has struck a deal to buy Biolab, of Auckland, New Zealand, for about $120 million. The acquisition of Biolab—a supplier of analytical instruments, lab equipment, and research materials—expands Thermo’s market presence in New Zealand, Australia, and the South Pacific, according to Thermo. Biolab is the scientific and healthcare unit of multi-industry firm Alesco (ASX:[[ticker:ALS]]), headquartered in Sidney, Australia, and Thermo plans to integrate Biolab into its laboratory products and services division.
Author: Ryan McBride
Ryan is an award-winning business journalist who contributes to our life sciences and technology coverage. He was previously a staff writer for Mass High Tech, a Boston business and technology newspaper, where he and his colleagues won a national business journalism award from the Society of American Business Editors and Writers in 2008. In recent years, he has made regular TV appearances on New England Cable News.
Prior to MHT, Ryan covered the life sciences, technology, and energy sectors for Providence Business News. He graduated with honors from the University of Rhode Island in 2001 with a bachelor’s degree in communications. When he’s not chasing down news, Ryan enjoys mountain biking and skiing in his home state of Vermont.
View all posts by Ryan McBride
